TY - JOUR
T1 - Glycosylation of Cancer Stem Cells
T2 - Function in Stemness, Tumorigenesis, and Metastasis
AU - Barkeer, Srikanth
AU - Chugh, Seema
AU - Batra, Surinder K.
AU - Ponnusamy, Moorthy P.
N1 - Publisher Copyright:
© 2018 The Authors
PY - 2018/8
Y1 - 2018/8
N2 - Aberrant glycosylation plays a critical role in tumor aggressiveness, progression, and metastasis. Emerging evidence associates cancer initiation and metastasis to the enrichment of cancer stem cells (CSCs). Several universal markers have been identified for CSCs characterization; however, a specific marker has not yet been identified for different cancer types. Specific glycosylation variation plays a major role in the progression and metastasis of different cancers. Interestingly, many of the CSC markers are glycoproteins and undergo differential glycosylation. Given the importance of CSCs and altered glycosylation in tumorigenesis, the present review will discuss current knowledge of altered glycosylation of CSCs and its application in cancer research.
AB - Aberrant glycosylation plays a critical role in tumor aggressiveness, progression, and metastasis. Emerging evidence associates cancer initiation and metastasis to the enrichment of cancer stem cells (CSCs). Several universal markers have been identified for CSCs characterization; however, a specific marker has not yet been identified for different cancer types. Specific glycosylation variation plays a major role in the progression and metastasis of different cancers. Interestingly, many of the CSC markers are glycoproteins and undergo differential glycosylation. Given the importance of CSCs and altered glycosylation in tumorigenesis, the present review will discuss current knowledge of altered glycosylation of CSCs and its application in cancer research.
UR - http://www.scopus.com/inward/record.url?scp=85049479495&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049479495&partnerID=8YFLogxK
U2 - 10.1016/j.neo.2018.06.001
DO - 10.1016/j.neo.2018.06.001
M3 - Review article
C2 - 30015157
AN - SCOPUS:85049479495
SN - 1522-8002
VL - 20
SP - 813
EP - 825
JO - Neoplasia (United States)
JF - Neoplasia (United States)
IS - 8
ER -